On the kinetics of the reaction between human antiplasmin and a low-molecular-weight form of plasmin
- PMID: 149657
- DOI: 10.1111/j.1432-1033.1978.tb12360.x
On the kinetics of the reaction between human antiplasmin and a low-molecular-weight form of plasmin
Abstract
The reaction between antiplasmin (A) and a low-molecular-weight form of plasmin (P) proceeds in at least two steps: a fast reversible second-order reaction followed by a slower irreversible first-order transition, and may be represented by: P +A k1 in equilibrium k-1 PA k2 leads to PA'. The low-Mr plasmin, which is obtained by limited elastase digestion, is composed of an intact B chain and a small A chain lacking the lysine-binding sites. The k1 of the reaction is (6.5 +/- 0.5) x 10(5) M-1 s-1 which is 30--60 times smaller than that for normal plasmin and antiplasmin. The dissociation constant of the first step is 1.9 x 10(-9) M which is 10 times higher than for normal plasmin and antiplasmin. The rate constant of the second step is (4.2 +/- 0.2) x 10(-3) s-1 for both normal and low-Mr plasmin. Low Mr plasmin which has substrate bound to its active site does not react or reacts only very slowly with antiplasmin. The reaction rate, however, is only slightly influenced by 6-aminohexanoic acid in concentrations up to 1 mM which decrease the reaction rate of normal plasmin approximately 50-fold. The findings further indicate that the lysine-binding site(s) of plasmin are of great importance for the rate of its reaction with antiplasmin.
Similar articles
-
Stopped-flow fluorescence kinetics of bovine alpha 2-antiplasmin inhibition of bovine midiplasmin.Biochem J. 1995 Jan 1;305 ( Pt 1)(Pt 1):97-102. doi: 10.1042/bj3050097. Biochem J. 1995. PMID: 7529997 Free PMC article.
-
On the specific interaction between the lysine-binding sites in plasmin and complementary sites in alpha2-antiplasmin and in fibrinogen.Biochim Biophys Acta. 1979 Jul 25;579(1):142-54. doi: 10.1016/0005-2795(79)90094-1. Biochim Biophys Acta. 1979. PMID: 157166
-
Kinetics of the reactions between streptokinase, plasmin and alpha 2-antiplasmin.Eur J Biochem. 1979 Oct;100(1):125-32. doi: 10.1111/j.1432-1033.1979.tb02040.x. Eur J Biochem. 1979. PMID: 158524
-
Reaction of human alpha2-antiplasmin and plasmin stopped-flow fluorescence kinetics.FEBS Lett. 1996 May 27;387(1):58-62. doi: 10.1016/0014-5793(96)00429-2. FEBS Lett. 1996. PMID: 8654567
-
Fast-acting plasmin inhibitor in human plasma.Blood. 1978 Apr;51(4):563-9. Blood. 1978. PMID: 147116 Review.
Cited by
-
Affinity-chromatographic purification of human alpha 2-antiplasmin.Biochem J. 1980 Oct 1;191(1):229-32. doi: 10.1042/bj1910229. Biochem J. 1980. PMID: 6907016 Free PMC article.
-
Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.Biochem J. 1992 Aug 15;286 ( Pt 1)(Pt 1):79-84. doi: 10.1042/bj2860079. Biochem J. 1992. PMID: 1381585 Free PMC article.
-
Fibrinolytic Enzymes for Thrombolytic Therapy.Adv Exp Med Biol. 2019;1148:345-381. doi: 10.1007/978-981-13-7709-9_15. Adv Exp Med Biol. 2019. PMID: 31482506 Review.
-
Stopped-flow fluorescence kinetics of bovine alpha 2-antiplasmin inhibition of bovine midiplasmin.Biochem J. 1995 Jan 1;305 ( Pt 1)(Pt 1):97-102. doi: 10.1042/bj3050097. Biochem J. 1995. PMID: 7529997 Free PMC article.
-
Tissue-type plasminogen activator. A review of its pharmacology and therapeutic use as a thrombolytic agent.Drugs. 1989 Sep;38(3):346-88. doi: 10.2165/00003495-198938030-00003. Drugs. 1989. PMID: 2509190 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources